TABLE 1
FROM:
Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study
H O Ersoz, K Ukinc, M Baykan, C Erem, I Durmus, A Hacihasanoglu and M Telatar
BACK TO ARTICLETable 1. Anthropometric, metabolic parameters, and ABPM results of the patients in the beginning of the study
| Group P (n=29) | Group M (n=28) | P | |
|---|---|---|---|
| Weight (kg) | 102.8 14.2 | 98.415.0 | NS |
| Body mass index (kg/m2) | 40.14.6 | 39.36.8 | NS |
| Waist circumference (cm) | 107.410.9 | 108.012.8 | NS |
| Hip circumference (cm) | 130.513.1 | 127.311.4 | NS |
| Waist/hip ratio | 0.830.08 | 0.850.07 | NS |
| Skin thickness | |||
| Triceps (cm) | 46.111.3 | 43.59.1 | NS |
| Biceps (cm) | 41.310.2 | 39.511.5 | NS |
| Subscapular (cm) | 47.010.3 | 45.79.4 | NS |
| Abdominal (cm) | 48.614.5 | 47.013.4 | NS |
| Fat mass (%) | 43.45.4 | 45.54.3 | NS |
| FPG (mg/dl) | 94.014.5 | 98.911.6 | NS |
Basal insulin ( U/ml) | 19.120.7 | 18.423.0 | NS |
| PIR | 4.505.10 | 4.605.40 | NS |
| Total cholesterol (mg/dl) | 190.534.4 | 192.626.1 | NS |
| HDL cholesterol (mg/dl) | 46.59.0 | 47.410.2 | NS |
| Triglyceride (mg/dl) | 146.082.1 | 152.672.5 | NS |
| LDL cholesterol (mg/dl) | 110.324.1 | 117.024.3 | NS |
| APO-A1 (mg/dl) | 126.819.7 | 135.338.7 | NS |
| APO-B (mg/dl) | 101.028.4 | 107.323.5 | NS |
| SBP (mmHg) | 120.39.9 | 118.19.3 | NS |
| DBP (mmHg) | 74.77.9 | 73.16.2 | NS |
| Pulse rate (beats/min) | 80.16.2 | 76.79.2 | NS |
| MAP (mmHg) | 90.37.6 | 89.37.1 | NS |
